Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Blood. 2011 Apr 14;117(15):e142-50. doi: 10.1182/blood-2010-12-323212. Epub 2011 Feb 22.
Forced expression of the transcription factor HoxB4 has been shown to enhance the self-renewal capacity of mouse bone marrow hematopoietic stem cells (HSCs) and confer a long-term repopulating capacity to yolk sac and embryonic stem (ES) cell-derived hematopoietic precursors. The fact that ES cell-derived precursors do not repopulate bone marrow without HoxB4 underscores an important role for HoxB4 in the maturation of ES-derived hematopoietic precursors into long-term repopulating HSCs. However, the precise molecular mechanism underlying this process is barely understood. In this study, we performed a genome-wide analysis of HoxB4 using ES cell-derived hematopoietic stem/progenitor cells. The results revealed many of the genes essential for HSC development to be direct targets of HoxB4, such as Runx1, Scl/Tal1, Gata2, and Gfi1. The expression profiling also showed that HoxB4 indirectly affects the expression of several important genes, such as Lmo2, Erg, Meis1, Pbx1, Nov, AhR, and Hemgn. HoxB4 tended to activate the transcription, but the down-regulation of a significant portion of direct targets suggested its function to be context-dependent. These findings indicate that HoxB4 reprograms a set of key regulator genes to facilitate the maturation of developing HSCs into repopulating cells. Our list of HoxB4 targets also provides novel candidate regulators for HSCs.
转录因子 HoxB4 的强制表达已被证明可以增强小鼠骨髓造血干细胞(HSCs)的自我更新能力,并赋予卵黄囊和胚胎干细胞(ES)细胞衍生的造血前体细胞长期重编程能力。事实上,如果没有 HoxB4,ES 细胞衍生的前体细胞就不会重编程骨髓,这突出了 HoxB4 在 ES 衍生的造血前体细胞成熟为长期重编程 HSCs 中的重要作用。然而,这一过程的确切分子机制几乎不为人知。在这项研究中,我们使用 ES 细胞衍生的造血干/祖细胞对 HoxB4 进行了全基因组分析。结果表明,许多对 HSC 发育至关重要的基因是 HoxB4 的直接靶标,如 Runx1、Scl/Tal1、Gata2 和 Gfi1。表达谱分析还表明,HoxB4 间接地影响了几个重要基因的表达,如 Lmo2、Erg、Meis1、Pbx1、Nov、AhR 和 Hemgn。HoxB4 倾向于激活转录,但直接靶标的很大一部分下调表明其功能依赖于上下文。这些发现表明,HoxB4 重新编程了一组关键调节基因,以促进发育中的 HSCs 成熟为重编程细胞。我们的 HoxB4 靶标列表还为 HSCs 提供了新的候选调节因子。